EC 3.4.21.73 - u- plasminogen activator

3D structures of EC 3.4.21.73 - u-plasminogen activator in Protein Data Bank

updated: 9 February 2012, 15:47

1. 1c5w: Structural Basis for Selectivity of a Small Molecule, S1- Binding, Sub-micromolar Inhibitor of Urokinase Type Plasminogen Activator
2. 1c5x: Structural Basis for Selectivity of a Small Molecule, S1- Binding, Sub-micromolar Inhibitor of Urokinase Type Plasminogen Activator
3. 1c5y: Structural Basis for Selectivity of a Small Molecule, S1- Binding, Sub-micromolar Inhibitor of Urokinase Type Plasminogen Activator
4. 1c5z: Structural Basis for Selectivity of a Small Molecule, S1- Binding, Sub-micromolar Inhibitor of Urokinase Type Plasminogen Activator
5. 1ejn: Urokinase Plasminogen Activator B-chain Inhibitor Complex
6. 1f5k: Urokinase Plasminogen Activator B-chain-benzamidine Complex
7. 1f5l: Urokinase Plasminogen Activator B-chain-amiloride Complex
8. 1f92: Urokinase Plasminogen Activator B Chain-uki-1d Complex
9. 1fv9: Crystal Structure of Human Microurokinase in Complex with 2- Amino-5-hydroxy-benzimidazole
10. 1gi7: A Novel Serine Protease Inhibition Motif Involving a Multi- Centered Short Hydrogen Bonding Network at The Active Site
11. 1gi8: A Novel Serine Protease Inhibition Motif Involving a Multi- Centered Short Hydrogen Bonding Network at The Active Site
12. 1gi9: A Novel Serine Protease Inhibition Motif Involving a Multi- Centered Short Hydrogen Bonding Network at The Active Site
13. 1gj7: Engineering Inhibitors Highly Selective for The S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets
14. 1gj8: Engineering Inhibitors Highly Selective for The S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets
15. 1gj9: Engineering Inhibitors Highly Selective for The S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets
16. 1gja: Engineering Inhibitors Highly Selective for The S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets
17. 1gjb: Engineering Inhibitors Highly Selective for The S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets
18. 1gjc: Engineering Inhibitors Highly Selective for The S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets
19. 1gjd: Engineering Inhibitors Highly Selective for The S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets
20. 1lmw: Lmw U-pa Structure Complexed with Egrcmk (glu-gly-arg Chloromethyl Ketone)
21. 3mhw: The Complex Crystal Structure of Urokianse and 2- Aminobenzothiazole
22. 3m61: Crystal Structure of Complex of Urokinase and a Upain-1 VARIANT(W3A) in Ph4.6 Condition
23. 3laq: Structure-based Engineering of Species Selectivity in The Upa-upar Interaction
24. 1o3p: Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-directed Serine Protease Inhibitors
25. 1o5a: Dissecting and Designing Inhibitor Selectivity Determinants at The S1 Site Using an Artificial Ala190 Protease (ala190 Upa)
26. 1o5b: Dissecting and Designing Inhibitor Selectivity Determinants at The S1 Site Using an Artificial Ala190 Protease (ala190 Upa)
27. 1o5c: Dissecting and Designing Inhibitor Selectivity Determinants at The S1 Site Using an Artificial Ala190 Protease (ala190 Upa)
28. 3kid: The Crystal Structures of 2-aminobenzothiazole-based Inhibitors in Complexes with Urokinase-type Plasminogen Activator
29. 3khv: Crystal Structures of Urokinase-type Plasminogen Activator in Complex with 4-(aminomethyl) Benzoic Acid and 4- (aminomethyl-phenyl)-methanol
30. 3kgp: Crystal Structures of Urokinase-type Plasminogen Activator in Complex with 4-(aminomethyl) Benzoic Acid and 4- (aminomethyl-phenyl)-methanol
31. 1owd: Substituted 2-naphthamidine Inhibitors of Urokinase
32. 1owe: Substituted 2-naphthamidine Inhibitors of Urokinase
33. 1owh: Substituted 2-naphthamidine Inhibitors of Urokinase
34. 1owi: Substituted 2-naphthamidine Inhibitors of Urokinase
35. 1owj: Substituted 2-naphthamidine Inhibitors of Urokinase
36. 1owk: Substituted 2-naphthamidine Inhibitors of Urokinase
37. 3ig6: Low Molecular Weigth Human Urokinase Type Plasminogen Activator 2-[6-(3'-aminomethyl-biphenyl-3-yloxy)-4-(3- Dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2- Yloxy]-4-dimethylamino-benzoic Acid Complex
38. 1sc8: Urokinase Plasminogen Activator B-chain-j435 Complex
39. 1sqa: Substituted 2-naphthamidine Inhibitors of Urokinase
40. 1sqo: Substituted 2-naphthamidine Inhibitors of Urokinase
41. 1sqt: Substituted 2-naphthamidine Inhibitors of Urokinase
42. 1u6q: Substituted 2-naphthamadine Inhibitors of Urokinase
43. 1vj9: Urokinase Plasminogen Activator B-chain-jt464 Complex
44. 1vja: Urokinase Plasminogen Activator B-chain-jt463 Complex
45. 1w0z: Urokinase Type Plasminogen Activator
46. 1w10: Urokinase Type Plasminogen Activator
47. 1w11: Urokinase Type Plasminogen Activator
48. 1w12: Urokinase Type Plasminogen Activator
49. 1w13: Urokinase Type Plasminogen Activator
50. 1w14: Urokinase Type Plasminogen Activator
51. 2vnt: Urokinase-type Plasminogen Activator Inhibitor Complex with a 1-(7-sulphoamidoisoquinolinyl)guanidine
52. 2viw: Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator
53. 2viv: Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator
54. 2viq: Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator
55. 2vip: Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator
56. 2vio: Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator
57. 2vin: Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator
58. 2r2w: Urokinase Plasminogen Activator B-chain-gppe Complex
59. 2o8w: Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in Complex with Inhibitors
60. 2o8u: Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in Complex with Inhibitors
61. 2o8t: Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q) in Complex with Inhibitors
62. 2fd6: Structure of Human Urokinase Plasminogen Activator in Complex with Urokinase Receptor and an Anti-upar Antibody at 1.9 a
63. 2i9a: Crystal Structure of The Free Aminoterminal Fragment of Urokinase Type Plasminogen Activator (atf)
64. 2i9b: Crystal Structure of Atf-urokinase Receptor Complex
65. 3pb1: Crystal Structure of a Michaelis Complex between Plasminogen Activator Inhibitor-1 and Urokinase-type Plasminogen Activator
66. 3mwi: The Complex Crystal Structure of Urokianse and 5-nitro-1h-indole-2- Amidine
67. 3ox7: The Crystal Structure of Upa Complex with Peptide Inhibitor Mh027 at Ph4.6
68. 3oy5: The Crystal Structure of Upa Complex with Peptide Inhibitor Mh027 at Ph7.4
69. 3oy6: The Crystal Structure of Upa Complex with Peptide Inhibitor Mh036 at Ph4.6